TP53 and cancer: For example, mutant p53 affects innate immunity and promotes cancer (Yang et al., 2014), whereas high SOX17 expression in CRC reduces CD8+ T-cell infiltration, allowing cancer cells to evade immune surveillance (Zamarron and Chen, 2011).